By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS


Industry
Services

Segment
Publisher





Company News
SVIN President Tudor Jovin , MD, Co-Leads Groundbreaking Stroke Study In The New England Journal of Medicine 4/21/2015 10:00:56 AM
Merck & Co. (MRK) Release: Treatment Of Advanced Non-Small Cell Lung Cancer (NSCLC) With Pembrolizumab Presented At AACR Annual Meeting And Published In The New England Journal of Medicine 4/20/2015 9:40:19 AM
Celgene (CELG) Release: Phase II Data For Apremilast In Behçet’s Disease Published In The New England Journal of Medicine 4/16/2015 11:19:44 AM
CombiMatrix Corporation (CBMX) Release: The New England Journal of Medicine Article Supports Importance Of Follow-Up Diagnostic Testing Following Positive Noninvasive Prenatal Screening Test 4/10/2015 8:41:47 AM
Amgen (AMGN) Publishes Safety Analysis Of Investigational Cholesterol-Lowering Medication Repatha (evolocumab) In The The New England Journal of Medicine 3/16/2015 6:40:58 AM
Sanofi (SAN.PA), Regeneron (REGN): 18-Month Results Of ODYSSEY LONG TERM Trial With Praluent (Alirocumab) Published In The New England Journal of Medicine 3/16/2015 6:01:28 AM
The New England Journal of Medicine Publishes Positive Results From Clinical Study Of Neovasc Inc. (NVC)'s Reducer Product 2/5/2015 8:32:37 AM
Stryker Release: Study Published In The New England Journal of Medicine Finds Intra-Arterial Treatment For Clot Removal Is More Effective At Treating Stroke Than Standard Medical Care 12/17/2014 9:25:38 AM
Phase 3 Results Published In The New England Journal of Medicine Show Superiority Of Pfizer (PFE)’s XALKORI® (crizotinib) Compared To Platinum-Based Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer 12/4/2014 10:12:52 AM
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-APOCIII Rx Phase 2 Study In Patients With Familial Chylomicronemia Published In The New England Journal of Medicine 12/4/2014 7:16:46 AM
12345678910...
//-->